Vimarsana
Biggest News Aggregation in the World

Page 4 - Specific Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Specific Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Specific Diagnostics Today - Breaking & Trending Today

Antimicrobial Susceptibility Testing Market to Surpass US$ 5,808.92 Million by 2030 - Vimarsana News

Antimicrobial Susceptibility Testing Market to Surpass US$ 5,808.92 Million by 2030

/PRNewswire/ -- According to Coherent Market Insights, the global antimicrobial susceptibility testing market is estimated to be valued at US$ 3,525.75 million...

Antimicrobial Susceptibility Testing Market to Surpass US$ 5,808.92 Million by 2030 - Vimarsana News

Antimicrobial Susceptibility Testing Market to Surpass US$ 5,808.92 Million by 2030

/PRNewswire/ -- According to Coherent Market Insights, the global antimicrobial susceptibility testing market is estimated to be valued at US$ 3,525.75 million...

Specific Diagnostics announces that Nathan Clark, former GenMark Sales Leader, joins Specific Diagnostics as Strategic Account Director, US East - Vimarsana News

Specific Diagnostics announces that Nathan Clark, former GenMark Sales Leader, joins Specific Diagnostics as Strategic Account Director, US East

San Jose, California (PRWEB) May 06, 2022 -- May 5, 2022 – San Jose, California – FOR IMMEDIATE RELEASESpecific Diagnostics today announced the appointment

Source: prweb.com
Specific Diagnostics Announces First French Tender Award and LIS Connectivity - Vimarsana News

Specific Diagnostics Announces First French Tender Award and LIS Connectivity

San Jose, California (PRWEB) February 15, 2022 -- February 15, 2022 – San Jose, California – FOR IMMEDIATE RELEASESpecific Diagnostics today announced its

Source: prweb.com
Gradientech Launches Clinical Study of AST System to Support Commercial Launch - Vimarsana News

Gradientech Launches Clinical Study of AST System to Support Commercial Launch

The company aims to secure the CE-IVD mark for use of its QuickMIC rapid AST system in sepsis and launch sales in Europe in coming months.

Source: 360dx.com